Revisto Secures $4M Seed Funding to Revolutionize Pharma Marketing
Key Highlights Revisto secures $4M in seed funding led by LiveOak Ventures, joined by Eli Lilly and others.…
Browsing Tag
Eli Lilly and Company
11 posts
TRexBio Closes $84M Series B to Advance Immune-Based Therapeutics
Key Highlights TRexBio raises $84M in Series B led by Delos Capital with new investors Avego BioScience and Agent…
Eli Lilly Appoints Lucas Montarce as Chief Financial Officer
Key Highlights Lucas Montarce named Executive Vice President and CFO at Eli Lilly. Joined Eli Lilly in 2001, holding multiple senior…
OrsoBio Closes $67 Million Series B Financing to Advance Obesity Therapies
Key Highlights OrsoBio secures $67M Series B financing, led by Ascenta Capital and Woodline Partners. Proceeds will accelerate…
Selkirk Pharma Appoints Colleen Dixon as New CEO
Key Highlights Selkirk Pharma announces Colleen Dixon as new CEO. Dixon brings over 30 years of biopharma experience.…
Radionetics Oncology Forms Strategic Relationship with Eli Lilly
Key Highlights Radionetics Oncology receives $140 million upfront cash payment. Eli Lilly secures exclusive acquisition rights for $1…
Radar Therapeutics Completes $13.4M Seed Financing to Advance Smart Programmable Medicines
Key Highlights Radar Therapeutics raises $13.4 million in seed financing led by NfX Bio. Investors include Eli Lilly and Company, Biovision…
Alloy Therapeutics and Eli Lilly Enter Licensing Agreement for Antibody Discovery
Key Highlights Alloy Therapeutics licenses ATX-Gx™ and ATX-CLC™ platforms to Eli Lilly. Non-exclusive agreement supports antibody drug discovery…
Inspirna Appoints Dr. Karim Benhadji as Chief Medical Officer
Key Highlights Dr. Karim Benhadji appointed as Chief Medical Officer, effective May 1, 2024. Robert Wasserman, M.D., retires and…
Alto Neuroscience Secures $45 Million in Oversubscribed Series C Financing
Key Highlights Oversubscribed $45 million Series C financing led by InVivium Capital, including new investors like Franklin Templeton and…